Literature DB >> 19674850

Expression profiling of integrins in lung cancer cells.

Linlang Guo1, Fan Zhang, Yingqian Cai, Tengfei Liu.   

Abstract

Integrins are heterodimeric transmembrane receptors consisting of 18 alpha and 8 beta subunits. Heterodimer composition of alpha and beta subunits has a potential for determining tumor subtypes of human lung cancer. The purpose of this study was to investigate the expression profile of integrins in lung cancer cells. Expression profiling of integrins in a panel of lung cancer cell line, including A549 (adenocarcinoma, ADC), Calu-1 (squamous carcinoma, SCC), H1650 (bronchioloalveolar carcinoma, BAC) and DMS-53 (small cell lung cancer, SCLC), was analyzed by cDNA microarrays, restriction analysis of gene expression (RAGE) and flow cytometry. Seventy-nine lung cancer specimens were used to further validate the data from cell lines using immunohistochemistry. Integrins are obviously expressed in a cell type-specific manner, such as alpha 3 in A549, Calu-1 and H1650 except in DMS53, alpha 4 in H1650, alpha 5 and beta1 in all cell lines. The integrins detected with cDNA microarrays were all unequivocally detected with RAGE and by flow cytometry at the protein level. In all lung cancer specimens, alpha 3 integrin was strongly expressed in ADC, SCC and BAC, but was infrequent in SCLC. alpha 4 integrin was solely expressed in BAC. alpha 5 and beta1 integrins were expressed in all four histological types of lung cancer specimens. Integrin alpha 3 and alpha 4 may be useful as diagnostic markers for adenocarcinoma, squamous cell carcinoma and bronchioloalveolar carcinoma. RAGE is a promising technique for studying the expression profiles of genes, such as integrins in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674850     DOI: 10.1016/j.prp.2009.07.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  15 in total

1.  Focal adhesion kinase-dependent activation of the early endocytic protein Rab5 is associated with cell migration.

Authors:  Cecilia Arriagada; Patricio Silva; Martial Millet; Luis Solano; Carolina Moraga; Vicente A Torres
Journal:  J Biol Chem       Date:  2019-07-10       Impact factor: 5.157

2.  Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer.

Authors:  Anne-Marie C Dingemans; Vivian van den Boogaart; Bettine A Vosse; Robert-Jan van Suylen; Arjan W Griffioen; Victor L Thijssen
Journal:  Mol Cancer       Date:  2010-06-17       Impact factor: 27.401

3.  Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.

Authors:  Vincent M Crowley; Dustin J E Huard; Raquel L Lieberman; Brian S J Blagg
Journal:  Chemistry       Date:  2017-09-27       Impact factor: 5.236

4.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

5.  Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.

Authors:  Petra Barros dos Santos; Juliana S Zanetti; Alfredo Ribeiro-Silva; Eduardo I C Beltrão
Journal:  Diagn Pathol       Date:  2012-08-16       Impact factor: 2.644

6.  Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors.

Authors:  Wenwu Xiao; Tianhong Li; Fernanda C Bononi; Diana Lac; Ivy A Kekessie; Yanlei Liu; Eduardo Sanchez; Anisha Mazloom; Ai-Hong Ma; Jia Lin; Jimmy Tran; Kevin Yang; Kit S Lam; Ruiwu Liu
Journal:  EJNMMI Res       Date:  2016-02-27       Impact factor: 3.138

Review 7.  Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.

Authors:  Narsireddy Amreddy; Anish Babu; Ranganayaki Muralidharan; Anupama Munshi; Rajagopal Ramesh
Journal:  Top Curr Chem (Cham)       Date:  2017-03-13

8.  CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.

Authors:  Jianjie Zhu; Tingting Cai; Jieqi Zhou; Wenwen Du; Yuanyuan Zeng; Ting Liu; Yulong Fu; Yue Li; Qian Qian; Xiuwei H Yang; Qinglin Li; Jian-An Huang; Zeyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2021-06-09

9.  Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop.

Authors:  Stacy Robertson; Alan L Parker; Carolyn Clarke; Margaret R Duffy; Raul Alba; Stuart A Nicklin; Andrew H Baker
Journal:  J Gen Virol       Date:  2016-05-16       Impact factor: 3.891

10.  Antibody neutralization of cell-surface gC1qR/HABP1/SF2-p32 prevents lamellipodia formation and tumorigenesis.

Authors:  Beom-Chan Kim; Hyun-Jung Hwang; Hyoung-Tae An; Hyun Lee; Jun-Sub Park; Jin Hong; Jesang Ko; Chungho Kim; Jae-Seon Lee; Young-Gyu Ko
Journal:  Oncotarget       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.